Core Viewpoint - The A-share market continues to strengthen, reaching a 10-year high, while the China Convertible Bond Index has also risen, hitting its highest point since June 2015 [1][3]. Group 1: Market Performance - The China Convertible Bond Index has shown a strong performance since 2025, highlighting its unique value in the equity market's volatility, characterized by "offensive and defensive" capabilities [2]. - On January 6, the China Convertible Bond Index surged by 1.35% to 505.77 points, marking a high not seen since June 2015 [4]. - The recent strong performance of convertible bonds is driven by the underlying stocks, with notable examples including the Seer Medical bond, which saw a 20% increase due to the stock's performance [5]. Group 2: Key Catalysts - The core catalyst for the current market rally is the commercialization breakthrough in the brain-computer interface industry, with significant announcements from companies like Neuralink [4]. - Domestic policy support for the brain-computer interface sector is also increasing, with initiatives aimed at expediting the approval processes for related medical devices [4]. Group 3: Structural Trends - The recent rally in convertible bonds is characterized by two main features: strong performance of underlying stocks and concentrated thematic interest in sectors like brain-computer interfaces and AI healthcare [5]. - Despite some convertible bonds experiencing declines due to falling stock prices, the overall market sentiment remains positive, driven by high-growth sectors [6]. Group 4: Historical Context - The last time the China Convertible Bond Index reached a historical high was in June 2015, during a peak in the A-share bull market [8]. - Since 2019, the convertible bond market has gradually recovered, with a notable resurgence in 2025, reflecting a strong correlation with the performance of underlying stocks [9]. Group 5: Future Outlook - Analysts suggest that the upcoming "spring rally" in the A-share and convertible bond markets may be influenced by seasonal capital inflows and policy expectations [12]. - The performance of convertible bonds in the near term will depend on institutional investment behavior and the release of annual performance forecasts for A-shares [12].

Core Viewpoint - The China Convertible Bond Index has reached a new high not seen in over a decade, reflecting its unique value in the volatile equity market, characterized by both offensive and defensive capabilities [1][2]. Group 1: Market Performance - On January 6, the China Convertible Bond Index surged by 1.35% to 505.77 points, marking the highest level since June 2015 [2]. - The recent performance of the index has been strong since 2025, highlighting its resilience amid fluctuations in the equity market [1][2]. - The strong performance of convertible bonds is closely linked to the performance of underlying stocks, with the index showing a rise of 18.66% in 2025, slightly outperforming the Shanghai Composite Index's 18.41% increase [5]. Group 2: Key Drivers - The core catalyst for the current market rally is the commercialization breakthrough in the brain-computer interface industry, with significant announcements from companies like Neuralink [3]. - Domestic policy support has intensified, with regulatory bodies accelerating the approval processes for related medical devices [3]. - Notable convertible bonds such as the Seli Convertible Bond have seen substantial gains, driven by the strong performance of their underlying stock, Seli Medical, which has been favored due to its advancements in AI and medical data [2][3]. Group 3: Market Trends and Analysis - Analysts have identified two main characteristics of the current convertible bond rally: the clear influence of underlying stock performance and the concentration of investment in high-growth sectors such as brain-computer interfaces and AI healthcare [3]. - The convertible bond market is experiencing a structural rally, with several bonds showing gains exceeding 10% [3]. - The market sentiment is expected to improve further due to seasonal capital inflows and policy expectations, potentially leading to a "spring rally" in the A-share and convertible bond markets [7].

人民财讯1月6日电，二连板麦澜德(688273)1月6日披露股票交易异动公告称，截至目前，公司在脑机接 口领域的产品尚处于研发及市场培育期，尚未实现规模化销售，暂未对公司业绩产生重大影响。技术路 线上，公司主要聚焦于非侵入式脑机接口技术的研发和产品化，与当前国际主流的侵入式脑机接口存在 显著技术路径差异。 ...

每经AI快讯，1月6日，麦澜德(688273.SH)发布股票交易异常波动公告称，截至目前，公司在脑机接口 领域的产品尚处于研发及市场培育期，尚未实现规模化销售，暂未对公司业绩产生重大影响。技术路线 上，公司主要聚焦于非侵入式脑机接口技术的研发和产品化，与当前国际主流的侵入式脑机接口存在显 著技术路径差异。 ...

蓝思科技（300433.SZ）1月6日在投资者互动平台表示，投资者您好！蓝思科技是强脑科技的战略投资 者，独家承接了强脑科技核心硬件模组的量产。2025年11月，蓝思与强脑科技共同向湖南省残联捐赠大 批智能仿生四肢，核心模组均来自蓝思产线。同时，公司与北美大客户已有10年以上深度合作，是其一 级核心供应商。公司凭借强脑科技等项目积累的量产经验以及强大的精密制造能力，正积极争取合作。 谢谢您的关注！ 有投资者在投资者互动平台提问：马斯克宣布2026年量产脑机接口设备，公司在脑机接口产业有布局 嘛？ （文章来源：每日经济新闻） ...

1月6日，三大指数集体收涨，沪指高开高走，再创十年新高。截至收盘，沪指涨1.5%，报4083.67点，创10年新高；深证成指涨1.4%，报14022.55点；创业 板指涨0.75%，报3319.29点。量能持续放大，沪深两市成交额2.81万亿，较上一个交易日放量2602亿。盘面上，市场热点轮番活跃，全市场超4100只个股上 涨，多达143只个股涨停，连续两日超百股涨停。 从板块来看，商业航天概念持续爆发，十余只成分股涨停，鲁信创投8天6板，北斗星通、中国卫通6天4板。脑机接口概念延续强势，三博脑科、美好医疗、 创新医疗2连板。大金融板块集体拉升，华林证券、大智慧涨停。智能驾驶概念走强，万集科技、路畅科技等多股涨停。化工板块走高，中泰化学、潞化科 技、氯碱化工涨停。有色金属板块表现活跃，洛阳钼业、紫金矿业等多股创历史新高。 今日市场（不含ST股、退市股）共120股涨停，连板股总数43只，25股封板未遂，封板率为83%。焦点股方面，胜通能源13连板、嘉美包装16天12板、锋龙 股份8连板、鲁信创投8天6板、雷科防务5连板、浙江世宝14天7板、三博脑科2天2板。 一、板块异动 二、涨跌停温度 三、涨跌家数 四、涨停 ...

Market Performance - The A-share market continues to show strong performance, with the Shanghai Composite Index achieving a 13-day winning streak, reaching its highest level since July 2015, closing at 4083.67 points, up 1.50% [3][5] - The Shenzhen Component Index rose by 1.40% to 14022.55 points, while the ChiNext Index increased by 0.75% to 3319.29 points. The total trading volume in the Shanghai and Shenzhen markets reached 283.26 billion, an increase of 26.51 billion from the previous day [3][5] Market Dynamics - The current market trend is characterized as a "short squeeze" rally, with the Shanghai Composite Index breaking through previous highs and maintaining a strong upward momentum [4][5] - Nearly 4000 stocks rose, with only 1210 declining, indicating a broad-based rally. The median increase among stocks was 0.8% [5] Sector Performance - The insurance sector led the market with a gain of over 4%, indicating its role as a core driver of the current rally since early December [5] - The securities sector also performed well, benefiting from prior adjustments, while the banking sector contributed to stabilizing the index despite initial declines [5] - Technology stocks, particularly in communications and semiconductors, faced adjustments, leading to a weaker performance in the ChiNext Index [6] Capital Flow - Significant capital outflows were observed in the communications sector, with approximately 11.1 billion leaving, while the securities sector saw a net inflow of 3.9 billion, indicating a potential shift in market focus [6] - The overall market experienced a net outflow of about 8 billion, despite the strong index performance, suggesting caution among investors [7] Future Outlook - The current market rally is seen as an early start to the spring market, but there are concerns regarding upcoming earnings reports that could impact speculative stock performance [7] - Investors are advised to monitor the performance of the Hang Seng Index and the Hang Seng Technology Index, which showed signs of a pullback towards the end of the trading day [7]

2025年，工业和信息化部等七部门联合发布了《关于推动脑机接口产业创新发展的实施意见》，设定了 2027年和2030年的清晰发展目标。同时，国家医保局为脑机接口项目单独立项收费，解决了支付端的关 键问题，行业标准也已出台，共同推动产业进入落地阶段。《中共中央关于制定国民经济和社会发展第 十五个五年规划的建议》中，脑机接口被明确列为需要前瞻布局的未来产业之一，旨在推动其成为新的 经济增长点。西南证券研报指出，结合七部委发布的《关于推动脑机接口产业创新发展的实施意见》可 以看出，脑机接口的应用将超越医疗康复，向工业制造、生活消费、教育娱乐等多领域拓展，最终目标 是让技术进步成果实现普惠共享。 资本市场的强烈反应，不仅源于脑机接口技术突破的利好，更基于对脑机接口行业广阔市场前景的预 期。Precedence Research及锐观咨询数据显示，2024年全球脑机接口市场规模约26亿美元，国内约32亿 元；预计到2034年全球脑机接口市场规模将增长至约124亿美元；而赛迪顾问预测，2024至2028年我国 脑机接口市场规模年均增速约20%，显著快于传统装备制造等成熟赛道。 开源证券研报分析认为，脑机接口行业正处于政策 ...

Group 1: Commercial Aerospace - China Aerospace Science and Technology Corporation's commercial rocket subsidiary increased its registered capital from 1 billion to 1.396 billion yuan, with a 77.6% increase in investment from the parent company [5] - Blue Arrow Aerospace is aiming to become the first publicly listed commercial rocket company, with the commercial aerospace sector expected to enter a golden development period [9] - The low-orbit satellite internet in China is set to enter mass launch construction in the second half of 2025, with significant acceleration in industry development anticipated by 2026 [11] Group 2: Brain-Computer Interface - The first fully implanted, wireless, and fully functional brain-computer interface product in China has successfully completed its first clinical trial [20] - The brain-computer interface industry is expected to reach a market size of over 10 billion USD by 2030, with companies like Haige Communication and Xiangyu Medical seeing significant stock price increases [22] - Xiangyu Medical is focusing on non-invasive rehabilitation and exploring invasive technologies, with plans to cover over 1,000 top-tier hospitals by 2026 [24] Group 3: Financial Sector - The National Financial Regulatory Administration has lowered risk factors for long-term holding assets, which is expected to cultivate patient capital and support technological innovation [30] - The financial sector is experiencing strong performance, with stocks like Zhina Compass seeing a significant increase in value due to market expectations of a bull market [31] Group 4: Intelligent Driving - Nvidia plans to test a driverless taxi service by 2027, indicating advancements in autonomous driving technology [33] - The first batch of L3 autonomous vehicles in China has begun large-scale road operation, with companies like Wanjite Technology benefiting from this trend [34] - The automatic driving technology is moving towards mass production applications, with companies like Haoen Automotive seeing stock price increases [36]

Group 1 - The core viewpoint of the article is the successful launch of the Fudan Innovation Investment Fund, which has completed its private fund product filing and is now operational [1] - The total scale of the Fudan Innovation Investment Fund is 1 billion yuan, co-founded by Fudan Innovation Mother Fund, Shanghai Future Industry Fund, and Jing'an Capital, with additional investors including Zhejiang Longsheng Group and Anhui Jinbiandan Equity Investment [1] - The fund will focus on strategic emerging industries such as life health, artificial intelligence, integrated circuits, new energy, and new materials, as well as future industries like quantum technology, biomanufacturing, hydrogen energy, nuclear fusion energy, brain-computer interfaces, embodied intelligence, and sixth-generation mobile communication [1]